Your session is about to expire
← Back to Search
Fitbit tracker for Cancer Survivors
Phase 2
Waitlist Available
Led By Elizabeth Kidd
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Life expectancy of at least one year
Stage IA-IIIA endometrial cancer patients with pathology reviewed at Stanford
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 9 months
Awards & highlights
Study Summary
This trial is testing a health and recovery program to see if it increases the level of physical activity in endometrial cancer survivors. The program includes exercise counseling, a Fitbit tracker, and phone or email/text communication.
Eligible Conditions
- Cancer Survivors
- Endometrial Cancer
- Uterine Corpus Cancer
- Uterine Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 9 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 9 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Increase in activity level measured using Fitbit tracker
Secondary outcome measures
Blood pressure
Body mass index (BMI)
Pulse
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Arm II (exercise counseling, Fitbit, email/text)Experimental Treatment5 Interventions
Participants undergo an exercise counseling session at baseline and wear Fitbit tracker daily for 9 months. Participants receive an electronic communication (email/text) of their choice at 2, 4, 6, and 8 weeks, and at 4 and 5 months stating the average number of daily steps over the past 2 weeks and encouraging a goal of a 10% increase over the next 2-4 week time period.
Group II: Arm I (exercise counseling, Fitbit, phone call)Experimental Treatment5 Interventions
Participants undergo an exercise counseling session at baseline and wear Fitbit tracker daily for 9 months. Participants receive a short phone call at 2, 4, 6, and 8 weeks, and at 4 and 5 months to discuss the average number of daily steps over the past 2 weeks and to encourage a goal of a 10% increase over the next 2-4 week time period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Telephone-Based Intervention
2017
Completed Phase 2
~3360
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,374 Previous Clinical Trials
17,332,880 Total Patients Enrolled
1 Trials studying Cancer Survivors
Elizabeth KiddPrincipal InvestigatorStanford University
2 Previous Clinical Trials
73 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are people with the required conditions able to enroll in this research project at this time?
"The clinical trial listed on clinicaltrials.gov is not recruiting patients at this time. The study was first posted December 1st, 2017 and last updated October 24th, 2022. There are currently 333 other trials that are actively looking for candidates to participate."
Answered by AI
Has the Fitbit tracker received government approval for use?
"While there is some evidence that the Fitbit tracker is safe, it remains unproven whether or not it actually works. Therefore, we've given it a score of 2."
Answered by AI
Share this study with friends
Copy Link
Messenger